Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and immunodeficiency disease.

F S Rosen1

  • 1Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115.

Ciba Foundation Symposium
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoregulatory T-cell defects.

Immunology today·2014
Same author

Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome.

Clinical and experimental immunology·2005
Same author

Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation.

Clinical and experimental immunology·2004
Same author

A novel protocol to identify mutations in patients with wiskott-Aldrich syndrome.

Blood cells, molecules & diseases·2002
Same author

The immunology series comes to an end.

The New England journal of medicine·2002
Same author

WASP and N-WASP in human platelets differ in sensitivity to protease calpain.

Blood·2001

Patients with primary immunodeficiency often develop autoimmune diseases, frequently targeting blood cells. Autoantibody production in these conditions can potentially be managed using anti-idiotypic antibodies.

Area of Science:

  • Immunology
  • Autoimmunity
  • Primary Immunodeficiency

Background:

  • Autoimmune diseases are common in patients with primary immunodeficiency.
  • Autoantibodies typically target blood cells like erythrocytes, platelets, and neutrophils.
  • Rarely, autoantibodies against lymphocytes can cause or exacerbate immunodeficiency.

Purpose of the Study:

  • To review the spectrum of autoimmune diseases associated with primary immunodeficiency.
  • To highlight the specific autoantibodies observed in different immunodeficiency states.
  • To discuss potential therapeutic strategies for autoantibody production.

Main Methods:

  • Literature review of autoimmune manifestations in primary immunodeficiency.
  • Analysis of autoantibody targets in various immunodeficiency syndromes.

Related Experiment Videos

  • Discussion of immunomodulatory approaches, including anti-idiotypic antibodies.

    • Main Results:

    • High incidence of autoantibodies against blood cells in primary immunodeficiency.
    • Specific patterns observed in IgA deficiency and hyper-IgM deficiency.
    • Drug allergy and contact dermatitis are common in B-lymphocyte deficiencies.
    • Organ-specific autoimmunity is rare in immunodeficiency.
    • Autoantibody production can be suppressed by anti-idiotypic antibodies.

    Conclusions:

    • Autoimmunity is a significant complication of primary immunodeficiency, predominantly affecting blood cells.
    • Understanding autoantibody targets is crucial for managing these patients.
    • Anti-idiotypic antibodies show promise in suppressing pathological autoantibody production.